How to Survive a Biotech Blowup

Posted On Nov 8, 2017 By Greg Guenthner

Big biotech stocks were primed and ready to rip higher at the beginning of the fourth quarter. But, the market threw a wrench in our gears. Today, Greg Guenthner tells you why its time to cash out on biotech…